Elasty G Plus (1syringe)

Here is a 310-word description of Elasty G Plus (1syringe):

Elasty G Plus (1syringe): Versatile Medium-Density HA Filler for Balanced Facial Rejuvenation

**Elasty G Plus**, manufactured by **A.M.I. (Advanced Medical Ingredients)**, is a **moderately cross-linked, medium G-prime (G’) hyaluronic acid (HA) dermal filler** presented in a standard **1.0 mL syringe**. Designed as a **versatile, all-rounder** within the Elasty line, it bridges the gap between the structural strength of Elasty D Plus and the fluidity of Elasty F Plus. It targets a broad range of indications requiring effective volumization, wrinkle correction, and contouring with a natural feel and predictable integration.https://skin-reboot.com/

**Core Technology & Properties:**
* **Balanced HA Concentration:** Contains an optimal HA concentration (typically 22-24 mg/mL) providing substantial filling power while maintaining spreadability.
* **Tri-Hyal Cross-Linking Technology:** Utilizes A.M.I.’s proprietary triple cross-linking method to create a **cohesive yet malleable** HA gel network. This results in:
* **Medium Elastic Modulus (G’):** Offers significant tissue support and lifting for moderate volume deficits, without excessive rigidity.
* **Moderate Cohesivity:** Ensures the gel maintains shape integrity for contouring while allowing for smooth tissue integration and spread in broader areas.
* **Optimized Viscoelasticity:** Balances elasticity (shape recovery) and viscosity (flow resistance) for durability, natural movement, and ease of injection.
* **Excellent Tissue Integration:** Blends smoothly with host tissues for a natural appearance and feel.
* **1.0 mL Syringe:** Standard volume presentation suitable for treating multiple areas or larger volume deficits in a single session.

**Mechanism of Action:**
1. **Immediate Correction:** Provides instant filling, volumization, and wrinkle effacement upon injection.
2. **Hydration:** HA binds water molecules, enhancing tissue hydration and skin quality.
3. **Collagen Stimulation:** Stimulates fibroblast activity, promoting gradual neocollagenesis for sustained tissue improvement.

**Primary Indications:**
* **Moderate Nasolabial Folds:** Correcting medium to deep folds from nose to mouth.
* **Marionette Lines:** Addressing lines from mouth corners down towards the chin/jawline.
* **Moderate Cheek & Midface Volume Loss:** Restoring youthful fullness and providing lift in the malar and submalar regions.
* **Lip Enhancement:** Adding body and volume, defining borders (requires technique adaptation compared to F Plus).
* **Pre-jowl Sulcus Correction:** Filling the depression anterior to the jowl.
* **Dorsal Hand Rejuvenation:** Correcting volume loss and prominent tendons/veins.
* **Tear Troughs (Experienced Injectors Only):** With cautious deep subdermal placement via cannula.
* **Temporal Hollowing (Mild to Moderate):** Restoring volume in the temples.

**Key Administration Considerations:**
* **Physician Expertise Required:** Should be administered by trained medical professionals proficient in facial anatomy and filler techniques.
* **Depth:** Injection depth varies: **mid-to-deep dermis** for folds/lips; **subcutaneous/deep dermal/supraperiosteal** for volumization (cheeks, pre-jowl). Adjust based on indication and skin thickness.
* **Technique:** Suitable for both **needles** (e.g., 27-29G) and **cannulas** (25-27G). Techniques include **linear threading, fanning, serial puncture, and bolus**.
* **Molding:** Gentle molding post-injection can optimize shape in areas like cheeks or lips.
* **Post-Treatment:** Common effects include swelling, redness, bruising, and tenderness, typically resolving within days to a week.
* **Longevity:** Results generally last **9-15 months**, varying by area, metabolism, and technique.
* **Potential Adverse Events:** Includes bruising, swelling, redness, tenderness, asymmetry, lumps/bumps (if superficial or uneven), infection, vascular compromise (avoid with proper technique/anatomy knowledge), Tyndall effect (if too superficial), and delayed inflammatory nodules.
* **Regulatory Status:** **CE marked** for use in Europe and many international markets. **Not FDA-approved in the USA.**

Elasty G Plus (1 syringe) offers a highly adaptable solution for comprehensive facial rejuvenation, effectively addressing moderate volume loss, deep folds, and contouring needs across multiple zones with balanced lifting power and natural integration, making it a cornerstone product for diverse treatment plans.CONTACT US